MyFinsight
Home
Blog
About
Back
Income Statement
AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Inc. (ABCL)
source: myfinsight.com
Comprehensive loss
-$56,160K
(-84.82%↓ Y/Y)
Net loss
-$55,427K
(-59.61%↓ Y/Y)
Foreign currency
translation adjustment
-$733K
(-116.89%↓ Y/Y)
Income tax recovery
-$3,538K
(-118.80%↓ Y/Y)
Grants and incentives
$3,854K
(4.39%↑ Y/Y)
Loss before income
tax
-$58,965K
(-62.24%↓ Y/Y)
Total other income
$3,812K
(-71.21%↓ Y/Y)
Research Fees
$3,901K
(-41.24%↓ Y/Y)
Licensing And Royalty
Revenue
$149K
Interest and other
-$42K
Loss from operations
-$62,777K
(-26.60%↓ Y/Y)
Total revenue
$4,050K
(-76.29%↓ Y/Y)
Total operating
expenses
$66,827K
(0.24%↑ Y/Y)
Research and development
$45,987K
(17.27%↑ Y/Y)
Sales, general, and
administrative
$13,850K
Depreciation and
amortization
$6,990K
Back